SolveLetter
Monthly insights on evidence strategy, medical communications, and AI tools for pharma teams.
Get SolveLetter in your inbox
1–2 articles per month. No spam. Unsubscribe anytime.
Join 1,200+ pharma professionals. Free forever.
Category
DOL Engagement
Best Practices for Engaging HCP DOLs Through Evidence-Based Content
How do you build a manageable system of scientific influence in digital channels? Four trends in DOL strategies, and the continuous content engine that makes the workload manageable.
AI Tools
21 AI-Integrated Tools for Working with Scientific & Medical Data
The use of AI-enabled tools in Medical Affairs has become a leading discussion topic. After two years of research and implementation, we share practical insights on tools that actually work for scientific and medical data workflows.
Advisory Boards
What Makes an Advisory Board Truly Insightful? New Trends, Smarter Ideas, and Next-Gen Formats
An advisory board is one of the most intelligent and powerful tools in the pharma arsenal. With the right event architecture, it helps generate valuable insights and build trust within the medical community.
Evidence Strategy
Why Do RWE and RWD Projects Face Challenges, and How Can We Avoid Them?
With evidence generation becoming a key performance indicator for many medical affairs teams, interest in RWE approaches is growing rapidly. Based on experience across a dozen projects, we’ve gathered insights that might be useful.
KOL Engagement
How to Increase Expert (KOL) Engagement in Congresses, Conferences, and Seminars?
Expert engagement at live events is declining. We explore practical solutions and formats that drive real KOL participation and meaningful scientific dialogue.
Newsletter
Get SolveLetter monthly in your inbox
Evidence strategy, advisory board insights, AI tools, and regulatory updates — curated for pharma medical affairs teams.
1–2 articles per month, never more
Practical insights from real projects
Free forever, unsubscribe anytime
Subscribe to SolveLetter
Join 1,200+ pharma professionals. No spam.
AI infrastructure
AI-powered.
Expert-validated.
We built AI workflows into our daily practice — not as a marketing claim, but as the infrastructure that lets our medical experts deliver faster without cutting corners.
Research
Structured PubMed queries with narrative or table outputs
Monitoring
Weekly literature digests by drug, target, or topic
AI-Enhanced EDC
Advisory board transcription + structured AI summary
Fact-Checker
Claim verification against your source documents
AI accelerates. Our experts validate.
Every output goes through expert medical review before it reaches your team. AI handles structure and speed — we handle scientific judgement and MLR readiness.
// Weekly digest: GLP-1 RA publications
monitor("GLP-1 receptor agonist", {
frequency: "weekly",
sources: ["pubmed", "congress_abstracts"]
})
Scanning 12 sources...
Weekly Digest · Feb 24–Mar 2
7 new publications found. 2 RCTs, 3 RWE studies, 2 meta-analyses. Key finding: MACE benefit confirmed in CVOT pooled analysis. Competitive alert: new data on tirzepatide...